Last edition
News about "HarmeeCare Pharmaceuticals"
Kilitch Drugs to Sell Ethiopian Subsidiary for USD 14 Million
Kilitch Drugs has planned to sell its Ethiopian subsidiary for USD 14 million, reallocating capital to Indian growth, debt repayment and pharma expansion.
HarmeeCare Pharmaceuticals | 24/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members